Folate-receptor-targeted radionuclide imaging agents

Chun Yen Ke, Carla J. Mathias, Mark Green

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

The cell-membrane folate receptor is a potential molecular target for tumor-selective drug delivery, including delivery of radiolabeled folate-chelate conjugates for diagnostic imaging. This review surveys the growing literature on tumor imaging with radionuclide agents targeted to the folate receptor. Successful folate-receptor targeting has been reported, both in vitro and in vivo, using a variety of radionuclides that are suitable for clinical diagnostic imaging (67Ga, 111In, 99mTc, 66Ga, and 64Cu). While none of these agents has, to date, been demonstrated to have clinical efficacy as a diagnostic tool, existing data indicates that it is feasible to noninvasively assess (at least qualitatively) tissue folate receptor levels by external radionuclide imaging.

Original languageEnglish (US)
Pages (from-to)1143-1160
Number of pages18
JournalAdvanced Drug Delivery Reviews
Volume56
Issue number8
DOIs
StatePublished - Apr 29 2004
Externally publishedYes

Fingerprint

Folic Acid
Radionuclide Imaging
Diagnostic Imaging
Radioisotopes
Neoplasms
Cell Membrane
Pharmaceutical Preparations

Keywords

  • Diagnostic imaging
  • Folate receptor
  • Nuclear medicine
  • Radiopharmaceutical

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Folate-receptor-targeted radionuclide imaging agents. / Ke, Chun Yen; Mathias, Carla J.; Green, Mark.

In: Advanced Drug Delivery Reviews, Vol. 56, No. 8, 29.04.2004, p. 1143-1160.

Research output: Contribution to journalArticle

Ke, Chun Yen ; Mathias, Carla J. ; Green, Mark. / Folate-receptor-targeted radionuclide imaging agents. In: Advanced Drug Delivery Reviews. 2004 ; Vol. 56, No. 8. pp. 1143-1160.
@article{2c132491015b4ad6827af2c23aa1aa76,
title = "Folate-receptor-targeted radionuclide imaging agents",
abstract = "The cell-membrane folate receptor is a potential molecular target for tumor-selective drug delivery, including delivery of radiolabeled folate-chelate conjugates for diagnostic imaging. This review surveys the growing literature on tumor imaging with radionuclide agents targeted to the folate receptor. Successful folate-receptor targeting has been reported, both in vitro and in vivo, using a variety of radionuclides that are suitable for clinical diagnostic imaging (67Ga, 111In, 99mTc, 66Ga, and 64Cu). While none of these agents has, to date, been demonstrated to have clinical efficacy as a diagnostic tool, existing data indicates that it is feasible to noninvasively assess (at least qualitatively) tissue folate receptor levels by external radionuclide imaging.",
keywords = "Diagnostic imaging, Folate receptor, Nuclear medicine, Radiopharmaceutical",
author = "Ke, {Chun Yen} and Mathias, {Carla J.} and Mark Green",
year = "2004",
month = "4",
day = "29",
doi = "10.1016/j.addr.2004.01.004",
language = "English (US)",
volume = "56",
pages = "1143--1160",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "8",

}

TY - JOUR

T1 - Folate-receptor-targeted radionuclide imaging agents

AU - Ke, Chun Yen

AU - Mathias, Carla J.

AU - Green, Mark

PY - 2004/4/29

Y1 - 2004/4/29

N2 - The cell-membrane folate receptor is a potential molecular target for tumor-selective drug delivery, including delivery of radiolabeled folate-chelate conjugates for diagnostic imaging. This review surveys the growing literature on tumor imaging with radionuclide agents targeted to the folate receptor. Successful folate-receptor targeting has been reported, both in vitro and in vivo, using a variety of radionuclides that are suitable for clinical diagnostic imaging (67Ga, 111In, 99mTc, 66Ga, and 64Cu). While none of these agents has, to date, been demonstrated to have clinical efficacy as a diagnostic tool, existing data indicates that it is feasible to noninvasively assess (at least qualitatively) tissue folate receptor levels by external radionuclide imaging.

AB - The cell-membrane folate receptor is a potential molecular target for tumor-selective drug delivery, including delivery of radiolabeled folate-chelate conjugates for diagnostic imaging. This review surveys the growing literature on tumor imaging with radionuclide agents targeted to the folate receptor. Successful folate-receptor targeting has been reported, both in vitro and in vivo, using a variety of radionuclides that are suitable for clinical diagnostic imaging (67Ga, 111In, 99mTc, 66Ga, and 64Cu). While none of these agents has, to date, been demonstrated to have clinical efficacy as a diagnostic tool, existing data indicates that it is feasible to noninvasively assess (at least qualitatively) tissue folate receptor levels by external radionuclide imaging.

KW - Diagnostic imaging

KW - Folate receptor

KW - Nuclear medicine

KW - Radiopharmaceutical

UR - http://www.scopus.com/inward/record.url?scp=16544383488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544383488&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2004.01.004

DO - 10.1016/j.addr.2004.01.004

M3 - Article

C2 - 15094212

AN - SCOPUS:16544383488

VL - 56

SP - 1143

EP - 1160

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 8

ER -